1. Home
  2. JDZG vs ITRM Comparison

JDZG vs ITRM Comparison

Compare JDZG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JDZG
  • ITRM
  • Stock Information
  • Founded
  • JDZG 2020
  • ITRM 2015
  • Country
  • JDZG China
  • ITRM Ireland
  • Employees
  • JDZG N/A
  • ITRM N/A
  • Industry
  • JDZG Other Consumer Services
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • JDZG Real Estate
  • ITRM Health Care
  • Exchange
  • JDZG Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • JDZG 18.4M
  • ITRM 35.6M
  • IPO Year
  • JDZG 2024
  • ITRM 2018
  • Fundamental
  • Price
  • JDZG $0.53
  • ITRM $1.05
  • Analyst Decision
  • JDZG
  • ITRM Strong Buy
  • Analyst Count
  • JDZG 0
  • ITRM 2
  • Target Price
  • JDZG N/A
  • ITRM $7.00
  • AVG Volume (30 Days)
  • JDZG 526.3K
  • ITRM 536.8K
  • Earning Date
  • JDZG 05-20-2025
  • ITRM 05-13-2025
  • Dividend Yield
  • JDZG N/A
  • ITRM N/A
  • EPS Growth
  • JDZG N/A
  • ITRM N/A
  • EPS
  • JDZG 0.03
  • ITRM N/A
  • Revenue
  • JDZG $2,567,741.00
  • ITRM N/A
  • Revenue This Year
  • JDZG N/A
  • ITRM N/A
  • Revenue Next Year
  • JDZG N/A
  • ITRM $108.39
  • P/E Ratio
  • JDZG $17.06
  • ITRM N/A
  • Revenue Growth
  • JDZG 20.36
  • ITRM N/A
  • 52 Week Low
  • JDZG $0.45
  • ITRM $0.81
  • 52 Week High
  • JDZG $15.08
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • JDZG N/A
  • ITRM 44.34
  • Support Level
  • JDZG N/A
  • ITRM $0.88
  • Resistance Level
  • JDZG N/A
  • ITRM $1.14
  • Average True Range (ATR)
  • JDZG 0.00
  • ITRM 0.10
  • MACD
  • JDZG 0.00
  • ITRM -0.01
  • Stochastic Oscillator
  • JDZG 0.00
  • ITRM 31.48

About JDZG JIADE LIMITED Common stock

Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: